Early midlife ovarian removal is associated with lower posterior hippocampal functionShow others and affiliations
2025 (English)In: Alzheimer's & Dementia: Journal of the Alzheimer's Association, ISSN 1552-5260, E-ISSN 1552-5279, Vol. 21, no 2, article id e14447Article in journal (Refereed) Published
Abstract [en]
INTRODUCTIONWomen with early bilateral salpingo-oophorectomy (BSO) have greater Alzheimer's disease (AD) risk than women with spontaneous menopause (SM), but the pathway toward this risk is understudied. Considering associative memory deficits may reflect early signs of AD, we studied how BSO affected brain activity underlying associative memory.METHODSEarly midlife women with BSO (with and without 17 beta-estradiol therapy [ET]) and age-matched controls (AMCs) with intact ovaries completed a face-name associative memory task during functional magnetic resonance imaging. Hippocampal activity along the anteroposterior axis during associative encoding and retrieval was compared among three groups (BSO [n = 28], BSO+ET [n = 35], AMCs [n = 40]).RESULTSBoth BSO groups (with and without ET) showed lower posterior hippocampal activation during encoding compared to the AMC group. However, this difference in activation was not significantly correlated with associative memory task performance.DISCUSSIONEarly 17 beta-estradiol loss may influence posterior hippocampal activity during associative encoding, possibly presaging late-life AD.Highlights After ovarian removal, changes in hippocampal function may affect dementia risk. Midlife ovarian removal is associated with less activation in the posterior hippocampus. Estradiol therapy may ameliorate alterations in brain function during learning.
Place, publisher, year, edition, pages
WILEY , 2025. Vol. 21, no 2, article id e14447
Keywords [en]
estradiol; functional magnetic resonance imaging; hippocampus; hormone therapy; menopause; oophorectomy
National Category
Geriatrics
Identifiers
URN: urn:nbn:se:liu:diva-210656DOI: 10.1002/alz.14447ISI: 001385091900001PubMedID: 39732509Scopus ID: 2-s2.0-85213698192OAI: oai:DiVA.org:liu-210656DiVA, id: diva2:1925373
Note
Funding Agencies|Canadian Institutes of Health Research (CIHR)-The Wilfred and Joyce Posluns Chair in Women's Brain Health and Aging; Canadian Cancer Society [310336]; Alzheimer Society of Canada [72953944]; Natural Sciences and Engineering Research Council of Canada [PGSD3-546667-2020]; General Motors Women in Science and Mathematics Award; CIHR Masters Award; Ontario Graduate Scholarship; CIHR Sex & Gender Research Chair; Canada Research Chairs Program; Medical Research Council of Southeast Sweden [ROE-658371]; Halsofonden the Research and Foundation Administration at Region Ostergotland; CIHR [ROE-796312, ROE-972344]; ALF Grants Region Ostergotland; Cancerfonden [301273]; Alzheimer's Association and Brain Canada Foundation [AARF-17-504715]; Jacqueline Ford Fund for Gender and Health; Ontario Brain Institute; Wilfred and Joyce Posluns Chair in Women's Brain Health and Aging; [WJP-150643]; [GS9-171369]; [CRC-2022-00240]; [FORSS-558511]; [MOP-130490]; [CNA-163902]; [MOP-143311]; [PJT162292]
2025-01-082025-01-082025-10-24